Maria E.L. van der Burg

Neoadjuvant Chemotherapy or Primary Surgery in Stage IIIC or IV Ovarian Cancer

Ignace Vergote, Claes G. Tropé, Frédéric Amant et al. · New England Journal of Medicine · 2010 · 2.5K citations · Full text

Medicine, Oncology, Surgery +17

The Effect of Debulking Surgery After Induction Chemotherapy on the Prognosis in Advanced Epithelial Ovarian Cancer

Maria E.L. van der Burg, M. van Lent, Marc Buyse et al. · Obstetrical & Gynecological Survey · 1995 · 580 citations

Medicine, Oncology, Surgery +11

Neoadjuvant chemotherapy versus debulking surgery in advanced tubo-ovarian cancers: pooled analysis of individual patient data from the EORTC 55971 and CHORUS trials

Ignace Vergote, Corneel Coens, Matthew Nankivell et al. · The Lancet Oncology · 2018 · 306 citations · Full text

Medicine, Oncology, Surgery +13

Prevention of Cisplatin Neurotoxicity with an ACTH(4–9) Analogue in Patients with Ovarian Cancer

R. Gerritsen van der Hoop, Charles J. Vecht, Maria E.L. van der Burg et al. · New England Journal of Medicine · 1990 · 287 citations · Full text

Medicine, Oncology, Pharmacology +17

Molecular profiling of platinum resistant ovarian cancer

Jozien Helleman, Maurice P.H.M. Jansen, Paul N. Span et al. · International Journal of Cancer · 2005 · 165 citations · Full text

Medicine, Molecular Biology, Oncology +17